Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 413 M716 M517 M923 M552 M714 M 2.71 B Non-Operating Income, Total 37 M11 M36 M-210 M52 M-22 M -144 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 20 M-1 M7 M-244 M8 M-33 M -262 M Unusual income/expense 17 M12 M29 M34 M44 M11 M 118 M Pretax income 170 M434 M246 M397 M295 M384 M 1.32 B Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 125 M408 M212 M615 M266 M392 M 1.49 B Discontinued operations —————— — Net income 125 M408 M212 M615 M266 M392 M 1.49 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 125 M408 M212 M615 M266 M392 M 1.49 B Basic earnings per share (Basic EPS) —————— — Diluted earnings per share (Diluted EPS) —————— — Average basic shares outstanding —————— — Diluted shares outstanding —————— — EBITDA 1.04 B1.31 B1.13 B1.55 B894 M962 M 4.53 B EBIT 125 M716 M517 M923 M266 M392 M 2.1 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 623 M594 M608 M625 M628 M570 M 2.43 B